Risk of Developing Hypertension in Atopic Dermatitis Patients Receiving Long-term and Low-dose Cyclosporine: A Nationwide Population-based Cohort Study

CONCLUSION: The incidence of CS-associated hypertension is very low when using low-dose treatment regimens for AD. However, the current use or a high cumulative dose of CS for treating patients with AD increases the risk of developing hypertension. Precaution is needed when prescribing CS for long-term treatment of AD.PMID:38576249 | PMC:PMC10995617 | DOI:10.5021/ad.23.099

Source: Annals of Dermatology - April 5, 2024 Category: Dermatology Authors: Yu Ri Woo Arum Choi Seo Won Song Suyeun Kim Sang Wook Son Sang Hyun Cho Sukil Kim Jung Eun Kim Source Type: research